Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease
- V M Salvati1,
- T T MacDonald2,
- M Bajaj-Elliott3,
- M Borrelli1,
- A Staiano1,
- S Auricchio1,
- R Troncone1,
- G Monteleone2
- 1Department of Pediatrics and European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, Naples, Italy
- 2Division for Infection, Inflammation, and Repair, University of Southampton, Southampton, UK
- 3Department of Paediatric and Adult Gastroenterology, St Bartholomews and the Royal London School of Medicine and Dentistry, London, UK
- Correspondence to:
G Monteleone, Division of Infection, Inflammation, and Repair, School of Medicine, Southampton General Hospital, MailPoint 813, Level E, South Academic Block, Tremona Road, Southampton SO16 6YD, UK;
- Accepted 1 May 2001
Background: Coeliac disease (CD) is caused by a T helper cell type 1 (Th1) response in the small intestinal mucosa to dietary gluten. Paradoxically, interleukin (IL)-12, the major Th1 inducing factor, is undetectable in the mucosa of active CD. IL-18 is a recently described cytokine capable of promoting T cell interferon (IFN)-γ production and facilitating Th1 cell polarisation.
Aim: To examine expression of IL-18 and IL-18-associated Th1 proteins in CD.
Methods: IL-18 and IFN-γ RNA transcripts were determined by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). IL-18 and caspase-1 protein expression were assessed by western blotting. Caspase-1 activity was determined using a commercially available assay. RNA transcripts for the IL-18 receptor subunits, IL-1 receptor related protein (IL-1 Rrp) and accessory protein-like subunit (AcPL), and IL-18 induced Th1 specific T box transcription factor (T-bet) were measured by RT-PCR and Southern blotting.
Results: IL-18 RNA transcripts were found in all mucosal samples analysed, with no difference between CD patients and controls. By western blot analysis, a large protein of approximately 24 kDa, corresponding to the immature IL-18, was detected in all mucosal samples from CD patients and controls. In contrast, mature IL-18 was only seen in CD patients. Immunoreactivity corresponding to both immature and mature caspase-1 was present in both CD and control samples. Tissue homogenates from CD patients and controls expressed similar levels of caspase-1 activity. IL-1Rrp and AcPL were seen in all samples but were expressed at greater levels in the mucosa of CD patients. T-bet was also upregulated in CD.
Conclusions: Active IL-18 is expressed in CD as well as other markers of Th1 polarisation.
- CD, coeliac disease
- IFN, interferon
- IL, interleukin
- T-bet, T box transcription factor
- IL-1Rrp, interleukin 1 receptor related protein
- AcPL, accessory protein-like
- RT-PCR, reverse transcriptase-polymerase chain reaction
- ICE, IL-1β converting enzyme
- Th1, T helper cell type 1
Coeliac disease (CD) is an enteropathy of the proximal small intestine characterised by villous atrophy, crypt cell hyperplasia, and increased numbers of intraepithelial lymphocytes. The lesion is caused by an excessive immune response to dietary gluten in genetically susceptible individuals.1 There is increasing evidence that CD4+ T cell mediated hypersensitivity plays a major role in tissue injury. Lamina propria CD4+ T cells are phenotypically activated and produce large amounts of T helper cell type 1 (Th1) cytokines in response to gluten stimulation.2 Functional studies have demonstrated that activation of lamina propria Th1 cells can modulate extracellular matrix deposition and epithelial proliferation.3–5
Differentiation of Th cells along the Th1 or Th2 pathway is influenced by many factors, such as the nature and concentration of the antigen, type of antigen presenting cells, and the microenvironment at the time of antigen exposure.6 The mechanism involved in the differentiation of Th1 cells in CD is not well understood. Paradoxically, interleukin (IL)-12, the major Th1 inducing cytokine, is undetectable in the mucosa of active CD.2,7 We recently demonstrated that interferon α (IFN-α), another cytokine that can promote Th1 differentiation and IFN-γ production in humans, is expressed in the mucosa of untreated CD patients.7 In addition, we have reported the occurrence of clinical CD in patients receiving IFN-α therapy, suggesting a role for this cytokine in promoting the local immune response in CD.7
IL-18 is a recently described cytokine produced by antigen presenting cells. The IL-18 gene encodes a precursor protein of approximately 24 kDa that is processed and cleaved by IL-1β converting enzyme (ICE) or caspase-1 into the mature active IL-18, a 18.3 kDa polypeptide.8 IL-18 binds to a receptor composed of two subunits, the binding protein interleukin 1 receptor related protein (IL-1Rrp) and the signalling chain accessory protein-like subunit (AcPL), which are expressed preferentially on T and natural killer cells.9,10 Recent work has shown a crucial role for IL-18 in maintaining the Th1 response in human diseases and experimental models.11–13 Indeed, IL-18 potentiates IL-12 or IFN-α dependent IFN-γ gene expression and protein secretion.14 The aim of our study was therefore to examine IL-18 and IL-18 associated Th1 factors in the mucosa of patients with CD.
MATERIALS AND METHODS
Duodenal mucosal samples obtained during upper endoscopy were immediately snap frozen and stored at −70°C. Twenty six CD patients (median age three years; range 0.8–57) and 21 controls (median age eight years; range 1.5–40) were analysed. In the CD group, one patient was on a gluten free diet and one was defined as latent CD (normal histology with increased intraepithelial γδ cells). The diagnosis of CD was based on ESPGHAN criteria.15 Controls included age matched patients who underwent upper endoscopy because of abdominal complaints, vomiting, diarrhoea, dyspepsia, growth failure, and autoimmune thyroiditis. In all, the duodenal mucosa was macroscopically and histologically normal. Mucosal colonic samples were also taken from four patients with active Crohn's disease undergoing colonoscopy and four patients with irritable bowel syndrome. All four Crohn's disease patients were not receiving treatment and had lesions confined to the colon. The study received ethics approval from the local committee (University Federico II, Naples, Italy).
Preparation of synthetic RNA for quantitative RT-PCR
To allow quantitation of IL-18 RNA transcripts by reverse transcriptase-polymerase chain reaction (RT-PCR), we constructed a competitor DNA molecule containing specific primer sequences encoded in exon 1 (7–33 bp) and exon 5 (11230–11 252 bp) of the genomic human IL-18 sequence. The primer sequence was as follows: sense 5`: 7GCTGCTGAACCAGTAGAAGACAATTGC33 3` and antisense 5`: 11252CCTTGATGTTATCAGGAGGATTC11230 3`. The above primer sequences were cloned into plasmid pMBEK, as described in detail previously.16 To generate standard RNA, the plasmid was linearised with HindIII and transcribed in vitro using T7 RNA polymerase under conditions recommended by the supplier (Promega, Biotech, Milan, Italy). Using the same primer set, RT-PCR for standard IL-18 yielded a PCR product of 478 bp whereas the test size was 384 bp. IFN-γ mRNA transcripts were also measured by competitive RT-PCR, as described previously.17
RNA extraction, cDNA preparation, and quantitative RT-PCR
Total RNA was extracted from whole mucosal duodenal biopsies from 16 active CD patients (median age two years; range 0.8–17.8) and 14 normal controls (median age 8.3 years; range 1.6–14) using the Trizol reagent (Gibco Life Technologies, Milan, Italy) according to the manufacturer's instructions, and quantified at 260 nm. The integrity of RNA was checked by electrophoresis on a 1.5% agarose gel. A constant amount of tissue RNA (0.2 μg for IL-18 and 1 μg for IFN-γ) and serial 10-fold dilutions of synthetic RNA (1 pg to 0.1 fg) were cotranscribed into complementary cDNA in a 20 μl reaction mixture containing 50 mM Tris, pH 8.3, 75 mM KCl, 3 mM MgCl2, 500 μM each dATP, dCTP, dTTP, and dGTP (Pharmacia Biotech, Milan, Italy), 10 mM DTT, 0.5 μg oligo (dT)12–18 (Pharmacia Biotech), and 100 U MMLV-RT (Gibco Life Technologies). A 5 μl sample of cDNA was then amplified under the following conditions: denaturation for one minute at 94°C, annealing for one minute at 58°C for IL-18 and 60°C for IFN-γ, and extension for one minute 15 seconds at 72°C for 37 cycles. Products were visualised on a 2% agarose gel using Vistra-Green dye (Amersham International, Milan, Italy). Densitometric analysis of fluorescent bands was carried out on STORM-860 by ImageQuant software (Molecular Dynamics, Inc, Sunnyvale, California, USA). The ratio of standard/target RNA was plotted against the starting number of standard RNA molecules on a double logarithmic scale to determine the molecule content in the sample for each transcript. Results are expressed as number of transcripts/μg total RNA.
Southern blot analysis
RNA expression of IL-1Rrp, AcPL, and T-bet was assessed semiquantitatively by Southern blotting. In preliminary experiments we established the optimal number of cycles to obtain a PCR product within the linear phase of the amplification. For this purpose, an equivalent amount of cDNA for sample was amplified using specific primers for β-actin (1 μl of cDNA for 23, 25, and 27 cycles), IL-1Rrp (2 μl of cDNA for 27, 30, and 33 cycles), AcPL (2 μl of cDNA for 28, 30, and 32 cycles), and T-bet (2 μl for 33, 35, and 40 cycles). PCR reactions were performed from 1 μg of total RNA in a total volume of 50 μl. For Southern blot experiments, cDNA samples were amplified with β-actin primers for 23 cycles, with IL-1Rrp for 30 cycles, with AcPL for 28 cycles, and with T-bet for 33 cycles. The primers were as follows: T-bet sense 5` GAGGGTCGCGCTCAACAAC 3` and antisense 5` GGATGCTGGTGTCAACAGATG 3`; IL-1Rrp sense 5` CCAGAAGGCAAATGGCATGCTTC 3` and antisense 5` CAACAGCTCCTCCAGGCACTAC 3`; AcPL sense 5` TCAGACGCTTGGGGATAAAA 3` and antisense 5` caagtaactgtgggcaaaacc 3`. β-actin primers have been published previously.12 To exclude amplification of genomic DNA contaminating the samples, experiments were also performed using RNA as substrate for PCR assay. The PCR conditions were denaturation for one minute at 94°C, annealing for one minute (58°C for IL-1 Rrp, 53°C for AcPL, 55°C for T-bet and β-actin), and extension for one minute 15 seconds at 72°C. The cDNA probes were DNA fragments encoding the full length PCR product. RT-PCR products were run on a 1% agarose gel and Southern blotting was performed according to a commercially available chemiluminescence detection kit (Amersham International).
Tissue homogenate preparation and western blotting
Protein analysis was performed on whole mucosal duodenal samples from 12 active CD patients (median age four years; range 0.8–57), one adult treated CD, one latent CD (10 years), and seven normal controls (median age 6.4 years; range 1.4–40). Biopsy specimens were placed in sterile tubes and homogenised using a tissue homogeniser in 300 μl of lysis buffer containing 25 mM Tris/HCl, pH=8, 50 mM NaCl, 10 μg/ml leupeptin, 2 μg/ml benzamidine, 20 μg/ml aprotinin, 50 μg/ml soybean trypsin inhibitor, 1 mM ethylene glycol-bis (β-aminoethyl ether) tetraacetic acid (EGTA), and 100 μg/ml phenylmethylsulphonylfluoride (all available from Sigma, Milan, Italy). After cell lysis the supernatant was collected, spun at 12000 rpm for 20 minutes (4°C), and stored at −70°C.
For detection of IL-18 or caspase-1, 50 μg of total protein were denatured by boiling for five minutes in Laemmli's sample buffer and separated on a 15% sodium dodecyl sulphate-polyacrylamide gel and electrophoretically transferred onto nitrocellulose membranes (Amersham) for 1–2 hours at 4°C at 100 V. IL-18 and caspase-1 protein were detected after incubation with a goat antihuman IL-18 (1:500 final dilution) or goat antihuman caspase-1 antibody (1:400 final dilution) (Santa Cruz Biotechnology, Santa Cruz, California, USA) recognising the active p20 subunit of caspase-1. The membrane was then incubated with horseradish peroxidase conjugated rabbit antigoat IgG monoclonal antibody (Dako, Cambridgeshire, UK) (final dilution 1:2500) and the reaction detected with ECL Plus kit (Amersham International). To confirm equal loading and transfer of proteins, ponceau S (Sigma) staining was performed.
Colorimetric caspase-1 assay
Total protein (80 μg), diluted to a volume of 50 μl with lysis buffer, was mixed with 50 μl of reaction buffer (100 mM Hepes, pH 7.5, 10% glycerol, 5 mM DTT, 0.5 mM EDTA) and incubated at 37°C for two hours in the presence of 200 μM caspase-1 substrate (Alexis Biochemicals, Lausen, Switzerland). Products of the reactions were read at 450 nm in a microtitre plate reader and normalised to the negative control.
Statistical analysis was performed using the non-parametric Mann-Whitney test for two independent samples.
Analysis of IL-18 gene and protein expression in the mucosa of active coeliac disease
To confirm that the CD lesion is associated with a preferential Th1 response, we first analysed the amount of transcripts for IFN-γ, the major Th1 lymphocyte derived cytokine, in the mucosa of patients with CD and controls. CD patients exhibited levels of IFN-γ RNA transcripts significantly higher than controls (CD: median 91 021 (range 2605–183 433) transcripts/μg total RNA; controls: median 1047 (range 227–8271) transcripts/μg total RNA; p<0.0002) (fig 1).
We then determined IL-18 RNA content by quantitative RT-PCR in the same samples analysed for IFN-γ. IL-18 RNA transcripts were detected in all mucosal samples with no significant difference between active CD patients and controls (CD: median 645 463 (range 285 315–1 797 792) transcripts/μg total RNA; controls: median 1 183 899 (range 470 106–1 613 114) transcripts/μg total RNA) (fig 2A). To examine whether IL-18 was regulated at the post-transcriptional level, IL-18 protein was analysed in 10 CD patients and four normal controls by western blotting. In all CD patients and controls, the anti-IL-18 antibody detected a larger protein of approximately 24 kDa (fig 2B). As we used a polyclonal antibody reacting with an epitope corresponding to an amino acid sequence mapping at the carboxy terminus of the human IL-18 precursor, the 24 kDa corresponds to the immature IL-18. In contrast, a protein of approximately 18 kDa comigrating with recombinant IL-18 and corresponding to the mature form of IL-18 was seen in 9/10 CD patients (including the treated and latent CD patient) but not in controls (fig 2B).
Active caspase-1 expression in the small intestinal mucosa of coeliac disease and control patients
Production of mature IL-18 requires the presence of the intracellular cysteine proteinase caspase-1 which is capable of converting immature IL-18 into the mature form.8 Caspase-1 is synthesised as a 45 kDa polypeptide precursor and subsequently cleaved into a mature form of 20 and 10 kDa.8 Immunoreactivity corresponding to mature caspase-1 was present in both CD and controls (fig 3A). Consistently, tissue homogenates from four CD patients and three normal controls expressed similar levels of caspase-1 activity (CD patients: mean 0.09 (SEM 0.014); controls: mean 0.107 (SEM 0.023)) (fig 3B).
IL-1Rrp and AcPL gene expression is upregulated in coeliac disease patients
Both IL-18 receptor subunits, IL-1Rrp and AcPL, have been reported to be expressed at high levels during Th1 responses, thereby maintaining the functional responsiveness of Th cells to IL-18.18 Therefore, we assessed whether IL-18 production was associated with enhanced IL-18R expression in CD mucosa. RNA transcripts for both chains, IL-1Rrp and AcPL, were seen in all mucosal samples from CD patients and controls. However, a more pronounced expression of both IL-18 R subunits was found in CD in comparison with controls (fig 4). There is no commercial antibody capable of specifically and selectively recognising the distinct IL-18R subunits. Therefore, based on these data, we cannot exclude the possibility that the documented differences at the RNA level are not associated with pronounced induction of IL-18R proteins.
Expression of T-bet, an IL-18 induced Th1 marker
The mechanism by which IL-18 facilitates IFN-γ production is not yet fully understood. In addition to a direct effect on IFN-γ gene promoter, IL-18 has recently been shown to enhance expression of T-bet, a Th1 specific T box transcription factor, which directly promotes differentiation of Th1 cells.19,20 As shown in fig 5A, T-bet transcripts were consistently present in all samples tested, even if more pronounced expression was seen in CD patients. In addition, T-bet was upregulated in the inflamed mucosa of patients with Crohn's disease, a disorder also associated with enhanced production of active IL-18 (fig 5B).
This study was designed to determine whether IL-18 is produced in the mucosa of CD patients. We found constitutive expression of IL-18 RNA in all intestinal samples tested, with no difference between CD and controls. In addition, in all CD and control samples, IL-18 RNA was efficiently translated, as indicated by the presence of the 24 kDa inactive protein in western blot experiments. However, the 18 kDa polypeptide, corresponding to the mature IL-18, was only seen in CD patients, raising the possibility that IL-18 in CD mucosa is regulated only at a post-translational level, as suggested in other human diseases and experimental models.11,21,22 The cellular source of IL-18 in the CD mucosa remains to be determined. However, previous studies have shown that in the gastrointestinal tract, IL-18 is mainly produced by macrophages, dendritic, and epithelial cells.12,23 Processing of the immature IL-18 into the mature form is mainly mediated by caspase-1 or IL-1-β converting enzyme (ICE).8 Caspase-1 is synthesised as a 45 kDa precursor that is subsequently cleaved into active subunits of 20 and 10 kDa 8. We found that both CD and control mucosal samples expressed the mature form of ICE and contained similar levels of caspase-1 activity. We do not know if in the normal duodenal mucosa, cells containing immature IL-18 also express active ICE. Our data suggest that other factors rather than caspase-1 might be involved in the processing of IL-18 in the gastrointestinal mucosa. This hypothesis is also supported by the demonstration that mature IL-18 is efficiently synthesised in caspase-1 deficient mice by a mechanism dependent on the interaction between Fas and Fas ligand,24 a pathway which has recently been described in CD.25 In this context, it is noteworthy that other caspases or caspase-like proteinases have been reported to cleave immature IL-18.26
IL-18 mediated signals are transduced through a receptor composed by two subunits, IL-1Rrp and AcPL, which are mainly expressed on Th1 cells in response to IFN-α and/or IL-12.18 Consistently, we found that both IL-18R chains were upregulated in CD in comparison with controls. However, we cannot locate which cells express IL-18R as there is no commercial antibody that specifically and selectively recognises both receptor subunits.
T-bet is a specific T box transcription factor which correlates with IFN-γ expression in Th1 and natural killer cells. T-bet is responsible for Th1 lineage development from naive Th cells and acts both by initiating Th1 genetic programmes and by repressing the opposing Th2 cell development.20 In this study we showed that T-bet was more pronounced in CD mucosa in comparison with normal duodenum. In addition, T-bet was upregulated in Crohn's disease, another intestinal Th1 associated disease, in which IL-18 is markedly upregulated.12 The fact that T-bet was found in the normal duodenum and colon is consistent with the demonstration that human intestinal lamina propria is infiltrated with IFN-γ secreting cells.27 Since in the human intestinal lamina propria of normal subjects the major Th1 inducing cytokines are virtually undetectable, it is conceivable that these IFN-γ secreting cells come from Peyer's patches, a site in which the high IL-12 facilitates differentiation of Th1 cells.2,7,12,28
A major histological feature of active CD is the marked infiltration of gluten specific activated T cells in the lamina propria of the small intestinal mucosa.1 Freshly isolated lamina propria T cells from coeliac patients have increased frequencies of IL-2 and IFN-γ secreting cells.29 In addition, the in vitro challenge of CD biopsies with gliadin induces a rapid increase in the number of CD25+ T cells and elicits high levels of IFN-γ transcripts.2,30 Many of these T cells are DQ2 restricted and of a Th1 or Th0 type with dominant IFN-γ production.31 The molecular mechanism involved in the differentiation of Th1 cells in CD however remains unknown. A possible mechanism is that naive T cells recruited from the blood are differentiated in situ along the Th1 pathway. Indeed, we have shown recently that in active CD mucosa, there is an exaggerated production of IFN-α, a cytokine that promotes Th1 cell development.7 Moreover, it is likely that Th1 cells primed in the Peyer's patches seed the lamina propria of CD patients where locally induced factors may contribute to maintain and expand the gluten specific Th1 response. In this context, IL-18 may play a major role, given that IL-18 can enhance IFN-γ synthesis and favour Th1 cell polarisation induced by either IL-12 or IFN-α.32,33
This work was supported by the European Union grant (ERBFMRXCT9). It also received financial support from the Commission of the European Communities, specific RTD programme “Quality of Life and Management of Living Resources”, QLRT-CT-1999-00037, “Evaluation of the prevalence of coeliac disease and its genetic components in the European population” (it does not necessarily reflect its views and in no way anticipates the Commission's future policy in this area), and by Ministero della Sanita' “Nuove terapie per il morbo coeliaco”. Virginia M Salvati received a grant for Young Investigators from the Italian Society for Paediatric Gastroenterology and Hepatology (SIGEP).